Site Maintenance October 29 – November 5
SCCM is currently performing major updates to its digital infrastructure to better serve members. Any website that requires an SCCM Customer ID and password to log in is currently unavailable until November 5, 2024. SCCM Customer Service and staff have limited capabilities, and response times will be longer during this time.
Margaret Parker, MD, MCCM, speaks with Joshua N. Goldstein, MD, PhD, FACEP, FAHA, about the article, “Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial,” published in The Lancet. Dr. Goldstein works as an Associate Professor of Surgery at Harvard Medical School. He also serves as Director of the Center for Neurologic Emergencies at Massachusetts General Hospital in Boston, Massachusetts. In this article, Dr. Goldstein and coauthors compared the efficacy and safety of four-factor prothrombin complex concentrate (4F-PCC) with that of plasma in VKA-treated patients needing urgent surgical or invasive procedures.
*If you are unable to play the podcast please click here to download the file.
